Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

656
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
656
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

466
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
466
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

337
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
337
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

887
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
887
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

629
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
629

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A Randomized Controlled Trial of Dual Upper-Extremity Training [DUET]: Combining Neurologic Music Therapy® with Noninvasive Brain Stimulation for Upper-Limb Performance in Corticobasal Syndrome.

Movement disorders clinical practice·2026
Same author

Dystonia in Parkinson's disease: Clinical characteristics and predictors of treatment response.

Parkinsonism & related disorders·2026
Same author

A sacred prelude to aphasia: Demystifying a diagnostic trinity.

Parkinsonism & related disorders·2026
Same author

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same author

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026

相关实验视频

Updated: Jun 8, 2025

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.7K

在宫 dystonia 的震.

Sinem Balta Beylergil1, Krishna Nikhil Mukunda1, Mohamed Elkasaby1

  • 1Department of Neurology, Case Western Reserve University, Cleveland, OH, United States.

Dystonia (Lausanne, Switzerland)
|November 8, 2024
PubMed
概括

机器学习确定了主要的临床特征,预测了宫 dystonia (CD) 患者的部震. 这有助于准确诊断和管理震,改善患者的护理和生活质量.

关键词:
宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia迪斯托尼亚 (Dystonia) 是一种精神疾病.一个的子.规律性的规律性.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

更多相关视频

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.3K

相关实验视频

Last Updated: Jun 8, 2025

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.7K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.3K

科学领域:

  • 神经学 神经学
  • 运动障碍 运动障碍
  • 机器学习在医学中的应用

背景情况:

  • 宫性 dystonia (CD) 是最常见的焦点 dystonia.
  • 大约三分之一的CD患者同时经历头部和手部震.
  • 准确的震评估在临床上具有挑战性,影响CD诊断和治疗.

研究的目的:

  • 确定临床特征,预测部震的存在和特征,在一个大队列的宫 dystonia 患者.
  • 利用机器学习来分析CD中的复杂临床数据.

主要方法:

  • 分析了全球37个中心最大的可用宫性 dystonia 患者队列 (n=3117).
  • 机器学习算法的应用,根据临床特征预测的存在和规律性.

主要成果:

  • 在3,117名CD患者中,有1367名患有部震,频率不同.
  • 较大的CD严重程度,较长的疾病持续时间和年龄较大预测了部震.
  • 女性性别与风险增加有关;其他身体部位的参与降低了震的可能性.

结论:

  • 机器学习有效地确定了CD中部震的预测性临床特征.
  • 这些发现可以提高部震描述和患者护理途径的准确性.